SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-004963
Filing Date
2020-01-10
Accepted
2020-01-10 06:05:02
Documents
4
Period of Report
2020-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d861995d8k.htm 8-K 24175
2 EX-99.1 d861995dex991.htm EX-99.1 9067
3 GRAPHIC g861995dsp2.jpg GRAPHIC 3232
4 GRAPHIC g861995g0110011210212.jpg GRAPHIC 3407
  Complete submission text file 0001193125-20-004963.txt   44130
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 20519371
SIC: 2834 Pharmaceutical Preparations